After the last Cochrane Review published in the Cochrane Library in December 2014 that found that electronic cigarettes may be helpful to smokers to stop smoking, the 2016 revised version addresses more specifically harm reduction and smoking cessation issues.
The original review (2014) was built on two randomized controlled trials (RCTs) and found that electronic cigarettes containing nicotine could increase the chances of stopping smoking within six to twelve months compared to using an electronic cigarette without nicotine. The researchers were however not able to determine whether electronic cigarettes was better or not compared to NRTs to stop smoking.
The 2016 version includes observational data from 11 studies regarding outcomes of vaping. None did find any outcome of vaping for up to two years. The studies showed that throat and mouth/noze irritation are the most commonly reported side effects in the short-to medium-term (up to two years), in the absence of long-term studies, given the relative novelty of the product.
Science 2.0 notices that there haven’t been any new randomized controlled trials with long-term outcomes looking at the effectiveness of electronic cigarettes in helping people to stop smoking. They explain that it is likely because the world leader in science, the United States, has put a de facto ban on the products by declaring anything made after 2007 must undergo FDA registration. The US Centers for Disease Control (CDC) and Prevention also conflates them with cigarettes, despite the fact that there is no smoke, and in the current politicization of science climate of the Obama administration, studies won’t get funded if the hypothesis is anything else.
Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews 2016, Issue 9. Art. No.: CD010216. DOI: 10.1002/14651858.CD010216.pub3.